Literature DB >> 6118172

Once daily beta-adrenoceptor blockade in hypertension: an ambulatory assessment.

S Mann, M W Craig, V Balasubramanian, E B Raftery.   

Abstract

1 The ambulant intra-arterial blood pressure of eighteen hypertensive subjects was monitored before and again after 3 months treatment with thrice daily sotalol (six patients), twice daily pindolol (six patients) and once daily pindolol (six patients). 2 Three patients in the sotalol group underwent a third study having changed to a once daily regimen; similarly six patients in the pindolol groups were restudied having crossed over to the alternative pindolol dosing regimen, total daily dosage being maintained in all cases. 3 Comparison of 24 h blood pressure curves before and after treatment showed effective daytime reduction but less consistent effects at night. 4 In the crossover experiments once daily and multiple daily dosing regimens produced identical patterns of reduction over 24 h in both blood pressure and heart rate. 5 It is inferred that in the treatment of hypertension, once daily dosing with standard preparations of beta-adrenoceptor blocking agents is probable adequate.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6118172      PMCID: PMC1401861          DOI: 10.1111/j.1365-2125.1981.tb01204.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man.

Authors:  R Gugler; W Höbel; G Bodem; H J Dengler
Journal:  Clin Pharmacol Ther       Date:  1975-02       Impact factor: 6.875

2.  The effect on blood pressure of beta-adrenoreceptor-blocking drugs given once daily.

Authors:  M Wilson; G Morgan; T Morgan
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

3.  Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

Authors:  H C Brown; S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

4.  Plasma pindolol levels and their significance in the assessment of cardiac beta blockade.

Authors:  A Bobik; G Jennings; P I Korner
Journal:  Med J Aust       Date:  1977-09-03       Impact factor: 7.738

5.  Beta-blockers: once or three times a day?

Authors:  T Reybrouck; A Amery; R Fagard; P Jousten; P Lijnen; E Meulepas
Journal:  Br Med J       Date:  1978-05-27

6.  Drug complience in hypertensive patients.

Authors:  A Marshall; D W Barritt
Journal:  Br Med J       Date:  1977-05-14

7.  Once-a-day pindolol in hypertension.

Authors:  Y M Traub; J B Rosenfeld
Journal:  Clin Pharmacol Ther       Date:  1977-05       Impact factor: 6.875

8.  To be taken as directed.

Authors:  M S Gatley
Journal:  J R Coll Gen Pract       Date:  1968-07

9.  Initial treatment of the young hypertensive: thiazide diuretic or beta-adrenoreceptor-blocking agent in a single daily dose?

Authors:  R D Gordon
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

10.  beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

View more
  11 in total

Review 1.  Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

2.  Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.

Authors:  W Schiess; D Welzel; R Gugler
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Ambulatory blood pressure during administration of atenolol, metoprolol, pindolol, and slow release propranolol.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-22

4.  The effect of once daily beta-adrenoceptor blocker-thiazide diuretic combination on the ambulatory blood pressure.

Authors:  B A Gould; R S Hornung; H Kieso; S Mann; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

5.  A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.

Authors:  R S Hornung; B A Gould; H Kieso; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1982-07       Impact factor: 4.335

6.  Effect on intra-arterial blood pressure of slow release metoprolol combined with placebo or chlorthalidone.

Authors:  H A Kieso; B A Gould; S Mann; R S Hornung; D G Altman; E B Raftery
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-10

7.  The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.

Authors:  M W Millar-Craig; S Mann; V Bala Subramanian; D G Altman; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

8.  Once daily nisoldipine in hypertension: cuff and ambulatory intra-arterial blood pressure.

Authors:  G Brigden; M Heber; M Caruana; A Lahiri; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  The effect of oxprenolol dosage time on its pharmacokinetics and haemodynamic effects during exercise in man.

Authors:  R Koopmans; B Oosterhuis; J M Karemaker; J Wemer; C J van Boxtel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

10.  Antihypertensive efficacy of twice daily controlled release diltiazem using 24 hour intra-arterial blood pressure monitoring.

Authors:  B S Sridhara; P Thomas; A Lahiri; E B Raftery
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.